M&A Deal Summary

Allergan Acquires Actavis Group

On April 25, 2012, Allergan acquired life science company Actavis Group for 4.3B EUR

Acquisition Highlights
  • This is Allergan’s 6th transaction in the Life Science sector.
  • This is Allergan’s 3rd largest (disclosed) transaction.
  • This is Allergan’s 1st transaction in Switzerland.

M&A Deal Summary
Date 2012-04-25
Target Actavis Group
Sector Life Science
Buyer(s) Allergan
Deal Type Add-on Acquisition
Deal Value 4.3B EUR

Target

Actavis Group

Zug, Switzerland
Actavis is a generic pharmaceutical companies, specializing in the development, manufacture and sale of generic pharmaceuticals. The company has operations in more than 40 countries, with over 10,000 employees. At present, Actavis has a portfolio which includes more than 1,000 medicines present on the market and registered in more than 70 countries.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Allergan

Parsippany, New Jersey, United States
Category Company
Founded 1956
Sector Life Science
Employees31,200
Revenue 15.8B USD (2018)
DESCRIPTION

Allergan is an integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company was originally established in 1956 and is based in Parsippany, New Jersey.

DEAL STATS #
Overall 10 of 38
Sector (Life Science) 6 of 23
Type (Add-on Acquisition) 9 of 31
Country (Switzerland) 1 of 1
Year (2012) 1 of 1
Size (of disclosed) 3 of 25
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-05-25 Specifar Pharmaceuticals S.A.

Athens, Greece

Specifar is a multinational generic pharmaceuticals company with its headquarters in Greece and representative offices in Europe. Specializing in development, production, distribution and sales & marketing, Specifar commits to delivering high-quality and affordable medicines to patients and its customers. Specifar employs approximately 460 people worldwide and has obtained more than 600 Marketing Authorizations in Europe, South Africa, Canada, the Middle East and Asia.

Buy €400M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-10-29 The Rugby Group

California, United States

Rugby OTC consists of more than 250 SKUs of cough and cold, allergy, pain relief, nausea relief, nicotine gum, vitamin and nutritional supplement products which are sold through various healthcare outlets across the United States.

Sell $117M
Mergr

Product

Company

Legal